Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00350155
Status:
COMPLETED
Last Update Posted:
2007-12-13
First Post:
2006-07-05
Brief Title:
Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 16-Day Randomized Double-Blind Double-Dummy Placebo-Controlled Parallel-Group Trial Comparing Lumiracoxib 100mg od With Naproxen 500 mg bid Plus Omeprazole 20mg od and Placebo in Healthy Volunteers to Investigate on the Safety and Tolerability of Lumiracoxib in the Small Bowel
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to investigate the potential differences in GI safety and tolerability in the small bowel between lumiracoxib conventional non-selective NSAID naproxen with a proton pump inhibitor omeprazole or placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None